You are here
ESSCB Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras
On November 14, 2011, the ESSCB Funding Committee voted to adopt a Statement Regarding the Conduct of Human Embryonic Stem Cell (hESC) Research Involving Chimeras, which was developed and...
New Model Informed Consent Forms
ESSCB Model Informed Consent Forms On November 14, 2011, the ESSCB Funding Committee approved five model informed consent forms developed by the ESSCB Ethics Committee. The forms provide guidance...
Stem Cell-Based Therapy for Radiation’s Side Effects on Brain Function
A recent paper from Viviane Tabar’s lab demonstrates the healing powers of hESC-derived oligodendrocyte progenitor cells in restoring brain function following radiation.
Governor Cuomo Announces $36 Million to Accelerate Development of Stem Cell-Based Disease Cures
Governor Andrew M. Cuomo today announced $36 million has been awarded to three research groups for the development of treatments for some of the most devastating conditions that could be helped with stem cell research.
Stem Cells Model Pediatric Brain Tumors
A new report from the lab of Viviane Tabar describes the ability to model a rare type of pediatric brain tumor for the first time using human embryonic stem cell-based techniques.
Governor Cuomo Announces More than $14 Million to Recruit and Educate the Next Generation of Stem Cell Science Researchers
Governor Andrew M. Cuomo on August 6 announced that more than $14 million in funding is available to promote and support stem cell research in New York State. Stem cell science is widely viewed by experts as the key to understanding and treating many of the most devastating conditions affecting New Yorkers and people worldwide. The official press release can be found at http://www.governor.ny.gov/press/08062014-stem-cell-researchers
A Vascular Niche Allows Reprogramming and Expansion of Engraftable Human Hematopoietic Cells
New research from the lab of Shahin Rafii identified a vascular niche that allows reprogramming and expansion of human hematopoietic progenitor cells capable of serial engraftment into mice.
CHK2 Involved in DNA Damage Response in Oocytes
New research from John Schimenti’s lab at Cornell sheds light on cell responses to DNA damage
Production of Cranial Placode from Human Stem Cells
Lorenz Studer and colleagues demonstrate how to differentiate human pluripotent stem cells into cranial placode.
Mechanism of Fragile X Syndrome Revealed
New research from Carl Schildkraut identifies the mechanism leading to silencing of the FMR1 gene and resulting in Fragile X syndrome.
Signals Controlling Liver Regeneration Revealed
New research from Shahin Rafii’s lab reveals signaling pathways that regulate liver regeneration in response to damage.
Michel Sadelain recognized for Thalassemia work
Dr. Michel Sadelain, at Memorial Sloan-Kettering Cancer Center, was recognized for his efforts to develop a new stem cell-based therapy for β-thalassemia patients by the Sultan Bin Khalifa International Thalassemia Award.